Valley Forge Asset Management’s AbbVie ABBV Stock Holding History

Valley Forge Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$7.91M	Buy	+133,535	New	+$7.69M	1.23%	40

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Valley Forge Asset Management's ABBV Position: Q4 2015 in Review

Valley Forge Asset Management opened a new position in AbbVie (ABBV) in Q4 2015: 133,535 shares worth $7.91M. The stake represents 1.23% of the portfolio and ranks #40 among its holdings.

1,635 funds tracked by Wall St. Rank hold ABBV as of Q4 2015.

Valley Forge Asset Management held 133,535 shares of AbbVie worth $7.91M as of Q4 2015.
AbbVie was a new Valley Forge Asset Management position in Q4 2015.
AbbVie made up 1.23% of Valley Forge Asset Management's portfolio in Q4 2015, its #40 holding.
1,635 funds tracked by Wall St. Rank held AbbVie as of Q4 2015.

Based on Valley Forge Asset Management's 13F filing for Q4 2015, filed 9 Feb 2016.